Viewing StudyNCT05648214



Ignite Creation Date: 2024-05-06 @ 6:22 PM
Last Modification Date: 2024-10-26 @ 2:47 PM
Study NCT ID: NCT05648214
Status: RECRUITING
Last Update Posted: 2024-06-17
First Post: 2022-12-05

Brief Title: A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Non-Alcoholic Fatty Liver Disease NAFLD
Sponsor: Regeneron Pharmaceuticals
Organization: Regeneron Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-12-27
Start Date Type: ACTUAL
Primary Completion Date: 2025-09-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-09-10
Completion Date Type: ESTIMATED
First Submit Date: 2022-12-05
First Submit QC Date: December 5 2022
Study First Post Date: 2022-12-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-20
Last Update Post Date: 2024-06-17
Last Update Post Date Type: ACTUAL